Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.
The John Innes Centre and its industrial and academic partners have been awarded UK Government funding to help deliver four ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the ...
Key takeawaysTau is the most common protein that aggregates in neurodegeneration diseases. However, researchers had not ...
Eli Lilly and Company (NYSE:LLY) is one of the best long term low volatility stocks to invest in. Eli Lilly and Company (NYSE:LLY) announced on January 30 significant plans to invest over $3.5 billion ...
The United Arab Emirates and Colossal Biosciences have announced the creation of the first Colossal BioVault and World ...
Amidst a backdrop of 'unfinished business', Sir Keir Starmer's Brexit reset is accelerating. Will he navigate the complex web ...
Biopreservation Market OverviewThe global biopreservation market is poised to witness strong growth, expanding at a compound ...
Dubai: Imagine standing in a room and watching a woolly mammoth move, hearing the rustle of its shaggy coat and feeling, for just a moment, as though a creature that vanished thousands of years ago ...
By the end of the 20th century,some scientists believed that the planet’s finite food resources would soon cap the world’s population. In his highly controversial 1968 book The Population Bomb, US ...
The Brighterside of News on MSN
Tiny protein pair discovery could reveal how the genetic code first began
Life runs on instructions you never see. Every cell reads DNA, turns that message into RNA, and then builds proteins that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results